Diazote suppository

The metronidazole contained in this product is an anti-anaerobic and anti-trichomonal drug; clotrimazole is a broad-spectrum antifungal drug, which has antibacterial effects on various superficial and deep fungi, and its mechanism of action is to inhibit the synthesis of fungal cell membranes and affect their metabolic processes; chlorhexidine acetate is a quaternary ammonium salt cationic surfactant, which has a bactericidal effect on Gram-positive bacteria. The combination of the three drugs has a synergistic effect, which is not only suitable for simple fungal, bacterial or trichomonal infections, but also for mixed infections.

This product is a compound preparation, each tablet contains the main ingredients of metronidazole 200 mg, clotrimazole 160 mg, chlorhexidine acetate 8 mg. The auxiliary materials are: molding agent semi-synthetic fatty acid glyceride, paraffin, softener lanolin.

This product is an off-white to creamy yellow suppository.

Used for bacterial vaginosis, candidal vulvovaginitis, trichomoniasis, and mixed bacterial, fungal and trichomoniasis vaginitis.

For vaginal administration, wash your hands before going to bed, take the suppository, remove the outer packaging, put on a finger cot, and insert the product deep into the vagina (posterior fornix), 1 capsule each time, 7 consecutive days as a course of treatment. Repeat the course of treatment after the first menstruation after stopping the drug.

Occasionally, skin rash, vaginal burning sensation, itching or other mucosal irritation symptoms may occur. Because this product can be absorbed from the mucosa, long-term and large-scale use may also produce the same adverse reactions as systemic medication: 1. It can cause epileptic seizures and peripheral neuropathy, the latter of which is mainly manifested by numbness and paresthesia of the extremities. In some cases, long-term use may cause persistent peripheral neuropathy. 2. Other common adverse reactions include: (1) Gastrointestinal reactions, such as nausea, loss of appetite, vomiting, diarrhea, abdominal discomfort, taste changes, dry mouth, metallic taste in the mouth, etc. (2) Reversible neutropenia. (3) Allergic reactions, such as skin rash, urticaria, itching, etc. (4) Central nervous system symptoms, such as headache, dizziness, syncope, paresthesia, limb numbness, ataxia and mental confusion, etc. (5) Other symptoms include increased serum aminotransferase, fever, cystitis, dysuria, dark urine color, etc., which are all reversible and will recover on their own after stopping the drug.

1. Patients who are allergic to azole (imidazole) drugs are prohibited from using this product. 2. Patients with active central nervous system diseases and blood diseases are prohibited from using this product. 3. Pregnant women are prohibited from using this product.

Precautions for children: Children should use with caution. Precautions for pregnancy and lactation: Pregnant women are prohibited from using this product. Precautions for the elderly: Due to decreased liver function, the pharmacokinetics of this product may change when used in the elderly, so it should be used with caution.

1. Chlorhexidine is incompatible with soap, potassium iodide, etc. It is also incompatible with borax, bicarbonate, carbonate, oxide, citrate, phosphate and sulfate. 2. When this product is used in combination with oxytetracycline, the latter may interfere with the effect of metronidazole in clearing vaginal Trichomonas. 3. Long-term and large-scale use, after absorption through the mucosa, may also produce drug interactions similar to systemic medications, such as inhibiting the metabolism of warfarin and other oral anticoagulants, interfering with disulfiram metabolism and serum aminotransferase and lactate dehydrogenase assay results, and combining with liver microsomal enzyme inducers or inhibitors to speed up or slow down the metabolism of this product in the liver. 4. Drug interactions may occur if used with other drugs. Please consult a physician or pharmacist for details.

[08] Cool storage area for external medicines (below 20°C)

36 months.

Tongyao Pharmaceutical Group Stock Co., Ltd.

• Founded in:

  2001-01-09

• Address:

  No. 39, Zhengxiu Road, Tonghua City

• Tax NO.:

  9122050170237316XN

• Registered Funds:

  117 million yuan

• Email:

  Log in to view